BET inhibition reveals glycolytic vulnerability via HIF1α in triple-negative breast cancer
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
In a groundbreaking study poised to reshape the therapeutic landscape of aggressive breast cancers, researchers have uncovered a novel metabolic ...
Mitochondria, long celebrated as the cellular powerhouses, have emerged as pivotal arbiters of cancer progression, especially in aggressive breast cancers ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine